Bristol Myers Squibb will become responsible for the development and any marketing of DF6002 and its related products worldwide ... it plans to advance R&D in oncology and haematology and is ...

Gilead has poached an oncology research leader from Bristol-Myers Squibb, appointing Michael ... discovery and development of eight marketed products and the advancement of more than 30 compounds ...

Bristol Myers Squibb is doubling down on a partnership with Medidata, signing a multiyear agreement to continue using the ...

Fangzhou Inc, a pioneer in internet healthcare solutions, announced a strategic alliance with Bristol Myers Squibb (BMS) China, a global biopharmaceutical company with a robust research and ...